Cargando…

Commercial use of health data—A public “trial” by citizens' jury

INTRODUCTION: Surveys suggest a dichotomy in how citizens view research for public benefit and research for commercial gain. Therefore, a research initiative, such as a learning health system, which works for both public and commercial benefit, may be controversial and lower public trust. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Tully, Mary P., Hassan, Lamiece, Oswald, Malcolm, Ainsworth, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802529/
https://www.ncbi.nlm.nih.gov/pubmed/31641688
http://dx.doi.org/10.1002/lrh2.10200
_version_ 1783460806135906304
author Tully, Mary P.
Hassan, Lamiece
Oswald, Malcolm
Ainsworth, John
author_facet Tully, Mary P.
Hassan, Lamiece
Oswald, Malcolm
Ainsworth, John
author_sort Tully, Mary P.
collection PubMed
description INTRODUCTION: Surveys suggest a dichotomy in how citizens view research for public benefit and research for commercial gain. Therefore, a research initiative, such as a learning health system, which works for both public and commercial benefit, may be controversial and lower public trust. METHODS: This study aimed to investigate what informed citizens considered to be appropriate uses of health data in a learning health system and why they made those decisions. Two‐paired 4‐day juries were run, with different jurors but the same purpose, expert witnesses, and facilitators. Overall, 694 people applied; 36 jurors were selected to match criteria based on demographics and privacy views. Jurors considered whether and why eight exemplars of anonymised patient data were acceptable. The exemplars were either planned initiatives to improve care pathways (Planned Examples) or possible commercial data uses (Potential Examples). RESULTS: These citizens' juries found that all Planned and two of the Potential Examples were considered appropriate by most, but not all, jurors because they could deliver public benefit. In general, positive health outcomes for patients were more acceptable than improved efficiency of services for the NHS, although they recognised that the latter also improved health. Jurors had concerns about whether improving efficiency would lead to inequitable distribution or closure of services, based on their existing understanding from media reports. Commercial gain that accrued secondary to this benefit was acceptable, with some jurors becoming more accepting of commercial uses as they understood them better. Prioritising profit, however, was unacceptable, regardless of any governance arrangements. CONCLUSIONS: Jurors tended to be more accepting of data sharing to both private and public sectors after the jury process. Many jurors accept commercial gain if public benefit is achieved. Some were suspicious of data sharing for efficiency gains. Juries elicited more informed and nuanced judgement from citizens than surveys.
format Online
Article
Text
id pubmed-6802529
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68025292019-10-22 Commercial use of health data—A public “trial” by citizens' jury Tully, Mary P. Hassan, Lamiece Oswald, Malcolm Ainsworth, John Learn Health Syst Research Reports INTRODUCTION: Surveys suggest a dichotomy in how citizens view research for public benefit and research for commercial gain. Therefore, a research initiative, such as a learning health system, which works for both public and commercial benefit, may be controversial and lower public trust. METHODS: This study aimed to investigate what informed citizens considered to be appropriate uses of health data in a learning health system and why they made those decisions. Two‐paired 4‐day juries were run, with different jurors but the same purpose, expert witnesses, and facilitators. Overall, 694 people applied; 36 jurors were selected to match criteria based on demographics and privacy views. Jurors considered whether and why eight exemplars of anonymised patient data were acceptable. The exemplars were either planned initiatives to improve care pathways (Planned Examples) or possible commercial data uses (Potential Examples). RESULTS: These citizens' juries found that all Planned and two of the Potential Examples were considered appropriate by most, but not all, jurors because they could deliver public benefit. In general, positive health outcomes for patients were more acceptable than improved efficiency of services for the NHS, although they recognised that the latter also improved health. Jurors had concerns about whether improving efficiency would lead to inequitable distribution or closure of services, based on their existing understanding from media reports. Commercial gain that accrued secondary to this benefit was acceptable, with some jurors becoming more accepting of commercial uses as they understood them better. Prioritising profit, however, was unacceptable, regardless of any governance arrangements. CONCLUSIONS: Jurors tended to be more accepting of data sharing to both private and public sectors after the jury process. Many jurors accept commercial gain if public benefit is achieved. Some were suspicious of data sharing for efficiency gains. Juries elicited more informed and nuanced judgement from citizens than surveys. John Wiley and Sons Inc. 2019-08-18 /pmc/articles/PMC6802529/ /pubmed/31641688 http://dx.doi.org/10.1002/lrh2.10200 Text en © 2019 The Authors. Learning Health Systems published by Wiley Periodicals, Inc. on behalf of University of Michigan This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Reports
Tully, Mary P.
Hassan, Lamiece
Oswald, Malcolm
Ainsworth, John
Commercial use of health data—A public “trial” by citizens' jury
title Commercial use of health data—A public “trial” by citizens' jury
title_full Commercial use of health data—A public “trial” by citizens' jury
title_fullStr Commercial use of health data—A public “trial” by citizens' jury
title_full_unstemmed Commercial use of health data—A public “trial” by citizens' jury
title_short Commercial use of health data—A public “trial” by citizens' jury
title_sort commercial use of health data—a public “trial” by citizens' jury
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802529/
https://www.ncbi.nlm.nih.gov/pubmed/31641688
http://dx.doi.org/10.1002/lrh2.10200
work_keys_str_mv AT tullymaryp commercialuseofhealthdataapublictrialbycitizensjury
AT hassanlamiece commercialuseofhealthdataapublictrialbycitizensjury
AT oswaldmalcolm commercialuseofhealthdataapublictrialbycitizensjury
AT ainsworthjohn commercialuseofhealthdataapublictrialbycitizensjury